Shigeto Yoshida

Title: Shigeto Yoshida: Innovator in Marek's Disease Virus Vaccines

Introduction

Shigeto Yoshida is a notable inventor based in Kamakura, Japan. He has made significant contributions to the field of veterinary medicine, particularly in the development of vaccines for Marek's disease.

Latest Patents

Yoshida holds a patent for Marek's disease virus vaccines aimed at providing protection against Marek's disease. The patent discloses a nucleotide sequence encoding the gp82 polypeptide of Marek's disease virus. It also details recombinant viruses that serve as vaccines, which preferably contain multiple genes encoding Marek's Disease Virus antigens, such as glycoprotein B and glycoprotein gp82. These genes are controlled by a poxvirus promoter within a non-essential region of the fowlpox virus DNA. Additionally, the patent describes a vaccine that exhibits a synergistic immunoprotective effect, combining a recombinant fowlpox virus expressing Marek's Disease Virus gB protein with turkey herpesvirus. A method for immunizing poultry using the disclosed vaccines is also provided. Yoshida has 1 patent to his name.

Career Highlights

Throughout his career, Shigeto Yoshida has focused on innovative solutions to combat Marek's disease, which poses a significant threat to poultry health. His work has contributed to advancements in vaccine technology, enhancing the protection of poultry against this viral disease.

Collaborations

Yoshida has collaborated with notable colleagues, including Lucy F Lee and Noboru Yanagida, to further his research and development efforts in the field of veterinary vaccines.

Conclusion

Shigeto Yoshida's contributions to Marek's disease virus vaccines highlight his commitment to improving poultry health through innovative research. His work continues to impact the field positively, providing essential solutions for disease prevention in livestock.